November 17 - 22, 2019
Hilton Boston Back Bay Hotel
Nov. 17-22, 2019Hilton Boston Back BayBoston, Massachusetts
Workshop CodirectorsGeorge D. Demetri, Dana-Farber Cancer Institute, Boston, MassachusettsSusan Band Horwitz, Albert Einstein College of Medicine, Bronx, New YorkPasi A. Jänne, Dana-Farber Cancer Institute, Boston, Massachusetts
An intensive week-long introduction to translational cancer research—including cancer medicine, the clinical cancer research environment, and collaborative team science—for basic scientists who are predoctoral students and postdoctoral fellows, early-career scientists, and senior scientists in transition to translational research.
This workshop is hosted in close collaboration with the Dana-Farber Cancer Institute/Harvard Cancer Center, which comprises Beth Israel Deaconess Medical Center, Brigham and Women’s Hospital, Children’s Hospital Boston, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, and Massachusetts General Hospital.
The Translational Cancer Research for Basic Scientists Workshop provides basic research scientists with essential training to adapt their research for maximum clinical impact and transition into a new career in translational cancer medicine. During the course of the week, attendees learn about the latest methods and approaches in cutting-edge translational cancer research from leading translational scientists in academia, government, and industry. This innovative workshop addresses many aspects of translational research, including collaborating on multidisciplinary teams, working effectively with industry partners, recognizing the unique needs and environment of the clinic and clinical laboratories, and navigating regulatory and compliance issues in translational science. This workshop also places a strong emphasis on understanding the perspective of patients and clinicians, allowing basic scientists to frame research questions in a broader context.
Previous workshops consisted of more than 25 faculty members providing core didactic lectures, nearly 15 additional health-care professionals participating as lab/discussion leaders, and more than 35 clinicians supervising offsite visits. We are excited to offer this outstanding educational program again to promote the professional development of early-career investigators in translational cancer research.
Comments from previous attendees:
For further information, please contact Lyngine Calizo, PhD, Assistant Director, at (215) 446-7265 or